ATU (France — cohort) in Bahrain
How the atu (france — cohort) pathway operates in Bahrain.
About ATU (France — cohort)
France's Authorization for Temporary Use, cohort form.
How ATU (France — cohort) works in Bahrain
Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.
Patients in Bahrain seeking access under ATU (France — cohort) typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Bahrain
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.